Evogene (EVGN) Inventory Average (2022 - 2025)
Evogene (EVGN) posted Inventory Average of $1.2 million for Q4 2025, down 42.92% sequentially from $2.0 million in Q3 2025, and down 29.13% YoY from $1.6 million in Q4 2024.
Evogene (EVGN) Inventory Average (2022 - 2025) Analysis & Trends
Evogene has reported Inventory Average for 4 years, with the latest figure at $1.2 million in Q4 2025.
- Quarterly Inventory Average fell 29.13% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.2 million (down 29.13% YoY) and the FY2025 annual result came in at $1.0 million, up 7.07% from the prior year.
- Inventory Average fell to $1.2 million in Q4 2025 per EVGN's latest filing, from $2.0 million in the prior quarter.
- Over five years, Inventory Average peaked at $2.1 million in Q2 2025 and troughed at $94500.0 in Q4 2023.
- A 4-year average of $828000.0 and a median of $499250.0 in 2023 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2023 and 2024: Inventory Average slumped 74.15% in 2023, then surged 1632.8% in 2024.
- Over 4 years, Inventory Average stood at $365500.0 in 2022, then plunged by 74.15% to $94500.0 in 2023, then soared by 1632.8% to $1.6 million in 2024, then declined by 29.13% to $1.2 million in 2025.
- According to Business Quant data, Inventory Average over the past three periods registered $1.2 million, $2.0 million, and $2.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Evogene | 4.38 Mn | 4.38 Mn | 204,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | 2.03 Mn |
| Jun 30, 2025 | 2.05 Mn |
| Mar 31, 2025 | 1.99 Mn |
| Dec 31, 2024 | 1.64 Mn |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 755,000.00 |
| Mar 31, 2024 | 396,000.00 |
| Dec 31, 2023 | 94,500.00 |
| Sep 30, 2023 | 181,000.00 |
| Jun 30, 2023 | 420,000.00 |
| Mar 31, 2023 | 578,500.00 |
| Dec 31, 2022 | 365,500.00 |
| Sep 30, 2022 | 163,500.00 |
| Jun 30, 2022 | 167,000.00 |
| Mar 31, 2022 | 132,000.00 |